Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
An announcement from China Touyun Tech Group ( (HK:1332) ) is now available.
Touyun Biotech Group Limited reported its unaudited interim results for the six months ending June 30, 2025, showing a significant turnaround with a profit of HK$28.05 million compared to a loss of HK$48.82 million in the same period in 2024. This improvement was driven by gains in other income and a reduction in losses from discontinued operations, positioning the company more favorably in its market.
More about China Touyun Tech Group
Touyun Biotech Group Limited operates in the biotechnology industry, focusing on treasury investment, money lending, and the sale of goods and services. The company is incorporated in Bermuda and is listed on the Hong Kong Stock Exchange under the stock code 1332.
Average Trading Volume: 207,396
Technical Sentiment Signal: Strong Sell
Current Market Cap: HK$227.3M
For an in-depth examination of 1332 stock, go to TipRanks’ Overview page.